Diurnal variation in choroidal thickness in relation to sex, axial length, and baseline choroidal thickness in healthy Korean subjects

Retina

Volumn 34, Issue 2, 2014, Pages 385-393

  Lee, Seung Won ^a   Yu, Seung Young ^a   Seo, Kyung Hoon ^a   Kim, Eung Suk ^b   Kwak, Hyung Woo ^a  

^a Kyung Hee University College of Medicine   (South Korea)

^b Eulji University   (South Korea)

Author keywords

Axial length; Choroidal thickness; Diurnal variation; Korean; Sex

Indexed keywords

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; AXIAL LENGTH, EYE; BLOOD PRESSURE; CHOROID; CIRCADIAN RHYTHM; FEMALE; HEALTHY VOLUNTEERS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; ORGAN SIZE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; SEX FACTORS; TOMOGRAPHY, OPTICAL COHERENCE; YOUNG ADULT;

EID: 84895073812     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182993f29     Document Type: Article

References (41)

1. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy. Ophthalmology 2010;117: 1792-1799.
2. McLeod DS, Grebe R, Bhutto I, et al. Relationship between RPE and choriocapillaris in age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50: 4982-4991.
3. Koizumi H, Yamagishi T, Yamazaki T, et al. Subfoveal choroidal thickness in typical age-related macular degeneration and polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2011;249: 1123-1128.
4. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 2011; 31: 510-517.
5. Nassif N, Cense B, Park BH, et al. In vivo human retinal imaging by ultrahigh-speed spectral domain optical coherence tomography. Opt Lett 2004;29: 480-482.
6. Wojtkowski M, Leitgeb R, Kowalczyk A, et al. In vivo human retinal imaging by Fourier domain optical coherence tomography. J Biomed Opt 2002;7: 457-463.
7. Branchini L, Regatieri CV, Flores-Moreno I, et al. Reproducibility of choroidal thickness measurements across three spectral domain optical coherence tomography systems. Ophthalmology 2012;119: 119-123.
8. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol 2008;146: 496-500.
9. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal thickness in polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Ophthalmology 2011;118: 840-845.
10. Maruko I, Iida T, Sugano Y, et al. Subfoveal retinal and choroidal thickness after verteporfin photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2011;151: 594-603.
11. Jirarattanasopa P, Ooto S, Tsujikawa A, et al. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy. Ophthalmology 2012;119: 1666-1678.
12. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina 2011;31: 1603-1608.
13. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011; 31: 502-509.
14. Fujiwara T, Imamura Y, Margolis R, et al. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol 2009;148: 445-450.
15. Ikuno Y, Tano Y. Retinal and choroidal biometry in highly myopic eyes with spectral-domain optical coherence tomography. Invest Ophthalmol Vis Sci 2009;50: 3876-3880.
16. Zeng J, Li J, Liu R, et al. Choroidal thickness in both eyes of patients with unilateral idiopathic macular hole. Ophthalmology 2012;119: 2328-2333.
17. Koss MC, Gherezghiher T. Adrenoceptor subtypes involved in neurally evoked sympathetic vasoconstriction in the anterior choroid of cats. Exp Eye Res 1993;57: 441-447.
18. Steinle JJ, Krizsan-Agbas D, Smith PG. Regional regulation of choroidal blood flow by autonomic innervation in the rat. Am J Physiol Regul Integr Comp Physiol 2000;279: 202-209.
19. Vance SK, Imamura Y, Freund KB. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina 2011; 31: 332-335.
20. Dallinger S, Bobr B, Findl O, et al. Effects of acetazolamide on choroidal blood flow. Stroke 1998;29: 997-1001.
21. Snyder SH, Bredt DS. Biological roles of nitric oxide. Sci Am 1992;266:68-71, 74-77.
22. Maul EA, Friedman DS, Chang DS, et al. Choroidal thickness measured by spectral domain optical coherence tomography: factors affecting thickness in glaucoma patients. Ophthalmology 2011;118: 1571-1579.
23. Nickla DL, Wallman J. The multifunctional choroid. Prog Retin Eye Res 2010;29: 144-168.
24. Newcombe RG, Duff GR. Eyes or patients? Traps for the unwary in the statistical analysis of ophthalmological studies. Br J Ophthalmol 1987;71: 645-646.
25. Brown JS, Flitcroft DI, Ying GS, et al. In vivo human choroidal thickness measurements: evidence for diurnal fluctuations. Invest Ophthalmol Vis Sci 2009;50: 5-12.
26. Chakraborty R, Read SA, Collins MJ. Diurnal variations in axial length, choroidal thickness, intraocular pressure, and ocular biometrics. Invest Ophthalmol Vis Sci 2011;52: 5121-5129.
27. Toyokawa N, Kimura H, Fukomoto A, et al. Difference in morning and evening choroidal thickness in Japanese subjects with no chorioretinal disease. Ophthalmic Surg Lasers Imaging 2012;43: 109-114.
28. Tan CS, Ouyang Y, Ruiz H, et al. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci 2012; 53: 261-266.
29. Usui S, Ikuno Y, Akiba M, et al. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci 2012;53: 2300-2307.
30. Li XQ, Larsen M, Munch IC. Subfoveal choroidal thickness in relation to sex and axial length in 93 Danish university students. Invest Ophthalmol Vis Sci 2011;52: 8438-8441.
31. Grieshaber MC, Staub JJ, Flammer J. The potential role of testosterone in central serous chorioretinopathy. Br J Ophthalmol 2007;91: 118-119.
32. Klein ML, Van Buskirk EM, Friedman E, et al. Experience with nontreatment of central serous choroidopathy. Arch Ophthalmol 1974;91: 247-250.
33. Spaide RF, Hall L, Haas A, et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina 1996;16: 203-213.
34. Wickham LA, Gao J, Toda I, et al. Identification of androgen, estrogen and progesterone receptor mRNAs in the eye. Acta Ophthalmol Scand 2000;78: 146-153.
35. Munaut C, Lambert V, Noel A, et al. Presence of oestrogen receptor type beta in human retina. Br J Ophthalmol 2001;85: 877-882.
36. Nickla D. The phase relationships between the diurnal rhythms in axial length and choroidal thickness and the association with ocular growth rate in chicks. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2006;192: 399-407.
37. Nickla DL, Wildsoet C, Wallman J. The circadian rhythm in intraocular pressure and its relation to diurnal ocular growth changes in chicks. Exp Eye Res 1998;66: 183-193.
38. Straubhaar M, Orgül S, Gugleta K, et al. Choroidal laser Doppler flowmetry in healthy subjects. Arch Ophthalmol 2000;118: 211-215.
39. Polska E, Simader C, Weigert G, et al. Regulation of choroidal blood flow during combined changes in intraocular pressure and arterial blood pressure. Invest Ophthalmol Vis Sci 2007; 48: 3768-3774.
40. Riva CE, Titze P, Hero M, et al. Choroidal blood flow during isometric exercises. Invest Ophthalmol Vis Sci 1997;38: 2338-2343.
41. Alwassia AA, Adhi M, Zhang JY, et al. Exercise-induced acute changes in systolic blood pressure do not alter choroidal thickness as measured by a portable spectral-domain optical coherence tomography device. Retina 2013;33: 160-165.